Elsa Y. Pioli
Macclesfield, ENG SK104TF, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.
Journal: Science translational medicine
Published: July 15, 2026
Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson's Disease.
Journal: Journal of medicinal chemistry
Published: June 09, 2021
Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease.
Journal: Heliyon
Published: July 20, 2020
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: March 15, 2020
Intraventricular dopamine infusion alleviates motor symptoms in a primate model of Parkinson's disease.
Journal: Neurobiology of disease
Published: January 22, 2020
Engrailed-1 induces long-lasting behavior benefit in an experimental Parkinson primate model.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 18, 2019
Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease.
Journal: Brain : a journal of neurology
Published: February 15, 2019
Meta-analysis of amantadine efficacy for improving preclinical research reliability.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 07, 2018
Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonism.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: January 17, 2018
An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in Primates.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 07, 2017
An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
Journal: Neuropharmacology
Published: February 11, 2016
Why bother using non-human primate models of cognitive disorders in translational research?
Journal: Neurobiology of learning and memory
Published: May 18, 2015
Last Updated: 09/26/2026